Home LiteratureArticle Details
PMID: 1265342 Published · ppublish English Journal Article

Allergic bronchoconstriction and its drug-induced reversal in anesthetized, ovalbumin-sensitized cats.

Research communications in chemical pathology and pharmacology ·Vol. 13 ·No. 4 ·1976-04-00 ·Pages 623-33

Barch GK, Talbott MW

Abstract

Cats, once thought to possess little immunological responsiveness, have recently been shown to manifest a wide range of immunologic reactions. Sensitization of cats with ovalbumin rendered the animals capable, after a latency period of 40 to 60 days, of anaphylactic shock upon intravenous challenge. Physiologically the response is characterized by bronchoconstriction as evidenced by an increase in airways resistance. This response was ameliorated by intravenous administration of either aminophylline or isoproterenol. Other reactions elicited upon challenge were dyspnea, cyanosis, and in some instances death. The parameters of the allergic response corresponded with those reported in previous studies of other experimental models of allergic bronchoconstriction.

MeSH Terms
Airway Resistance/drug effects Aminophylline/pharmacology Anesthesia Animals Bronchi/drug effects,physiopathology Cats Female Hypersensitivity/physiopathology Isoproterenol/pharmacology Male Ovalbumin/immunology Time Factors
Chemicals
Aminophylline Ovalbumin Isoproterenol
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Barch G K
Talbott M W
Article Info
Journal
Research communications in chemical pathology and pharmacology
Abbr.
Res Commun Chem Pathol Pharmacol
ISSN
0034-5164
Published
1976-04-00
Pages
623-33
Language
English
Region
United States
NLM ID
0244734
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]